352 results on '"Ahluwalia N"'
Search Results
2. WS01.04 Real-world outcomes in people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) with up to three years of follow-up
3. Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility
4. Exploring smartphone ownership, patient behaviour, and potential bias in wearables research for atrial fibrillation
5. The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study)
6. Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization
7. Episode-level characteristics of atrial fibrillation are associated with symptomatic events
8. 137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study
9. 133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
10. Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
11. 169 A phase 4, fully decentralized clinical trial to evaluate physical activity and cough frequency in patients with cystic fibrosis using wearable technology
12. Transseptal puncture for left atrial ablation: risk factors for cardiac tamponade and a proposed causative classification system
13. 163 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and at least one F508del alleles: 96-week interim results from an open-label extension study
14. 170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study
15. 185 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating or residual function mutation
16. Early results of the novel radiofrequency balloon ablation catheter for pulmonary vein isolation
17. Dietary patterns, inflammation and the metabolic syndrome
18. Erratum for Long‐term outcomes of index cryoballoon ablation or point‐by‐point radiofrequency ablation in patients with atrial fibrillation and systolic heart failure. J Cardiovasc Electrophysiol. 2021;32:941–948.
19. 562: Elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least 1 F508del allele: Interim results from a Phase 3 open-label extension study
20. Long-term outcomes of catheter ablation for ventricular arrhythmias in post- myocarditis patients; Insights from a meta-analysis of current datv
21. Association of macronutrient intake patterns with being overweight in a population-based random sample of men in France
22. A Phase 3 open-label study of ELX/TEZ/IVA in children 6 through 11 years of age with CF and at least one F508del allele
23. Long‐term outcomes of index cryoballoon ablation or point‐by‐point radiofrequency ablation in patients with atrial fibrillation and systolic heart failure
24. WS16.03 Registry-based study of people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA): Up to 2 years of real-world outcome data
25. Sleep and the control of breathing
26. A CONSIDERATION OF BIOMARKERS TO BE USED FOR EVALUATION OF INFLAMMATION IN HUMAN NUTRITIONAL STUDIES
27. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample
28. P504VT ablation outcomes and predictors in a UK population- validating existing predictors and novel markers
29. Catheter Management Across Patients with Hematologic Malignancies and Catheter-Related Blood Stream Infections: A Systematic Review
30. The ICU and Hospital Environment: Perspectives of Visitors to the ICU
31. The Association Between Nutritional Risk Index and ICU Mortality Across Hematologic Malignancy Patients with Acute Respiratory Failure
32. An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)
33. Socioeconomic position, macroeconomic environment and overweight among adolescents in 35 countries
34. Prevention of overweight in preschool children: results of kindergarten-based interventions
35. A rare infection of the gastric mucosa
36. An unusual cause of rectal bleeding
37. An unusual cause of melena
38. Rare presentation of a common illness
39. Effects of erythropoietin therapy on iron absorption in chronic renal failure
40. Evaluation of gastric antral motor performance in patients with dysmotility-like dyspepsia using real-time high-resolution ultrasound
41. Effect of distension and feeding on phasic changes in human proximal gastric tone
42. Educational Status, Coronary Heart Disease, and Coronary Risk Factor Prevalence in a Rural Population of India.
43. Doege–Potter Syndrome
44. LIN28B Polymorphism Could Modulate the Relationship Between Childhood Obesity and Age at Menarche Reply:Journal of Adolescent Health
45. Apport des biomarqueurs de l’adiosité, de l’inflammation et de la fonction endothéliale dans la prédiction du diabète de type 2 au sein de la cohorte SU.VI.MAX
46. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a prospective study
47. OP0209 Soluble Ephrin-B2 Ectodomain Contributes to the Pathogenesis of Systemic Sclerosis
48. Trends in overweight prevalence among 11-, 13- and 15-year-olds in 25 countries in Europe, Canada and USA from 2002 to 2010
49. Fruit and vegetable consumption trends among adolescents from 2002 to 2010 in 33 countries
50. Overweight in school-aged children and its relationship with demographic and lifestyle factors: results from the WHO-Collaborative Health Behaviour in School-aged Children (HBSC) Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.